EUVIMEDEUVIMED entdecken
Open Access

Myocarditis in Patients With Idiopathic Inflammatory Myopathies: Clinical Presentation and Outcomes

Melody P Chung iD, Jana Lovell, William Kelly, Christopher A Mecoli iD, Jemima Albayda iD, Lisa Christopher-Stine iD, Nisha A Gilotra iD, Julie J Paik iD

The Journal of Rheumatology · 2023-08 · 50 (8) · 1039-1046

DOI: 10.3899/jrheum.220989 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Rheumatology, online erschienen am 01.04.2023. Verfasst von Melody P Chung und 7 weiteren Autor:innen. Beteiligte Einrichtung: M.P. Chung, MD, MS, W. Kelly, BS, C.A. Mecoli, MD, MHS, J. Albayda, MD, L. Christopher-Stine, MD, MPH, J.J. Paik, MD, MHS, Division of Rheumatology, …. Hauptthemen laut MEDLINE: Myocarditis, Myositis. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To determine the clinical phenotype and outcomes of patients with idiopathic inflammatory myopathies (IIMs) and myocarditis.

Methods

Using the Johns Hopkins Myositis Center Research Registry, we identified 31 adult patients with IIM—out of a total of 3082 with confirmed or suspected muscle disease—with an encounter code of myocarditis from 2004 to 2021. Of these, 14 adult patients with IIM were adjudicated to have clinical myocarditis. Information about demographics, autoantibodies, and clinical outcomes was retrospectively collected and analyzed.

Results

Of 14 patients with IIM with clinical myocarditis, the median age at IIM diagnosis was 49 (IQR 35-56) years, and the median age at myocarditis diagnosis was 54 (IQR 36-61) years. The median duration between IIM diagnosis and myocarditis was 3 (IQR 2-9) years. The majority of patients were female (8/14, 57%) and Black (10/14, 71%). Antisynthetase syndrome was the most common IIM subtype (9/14, 64%). Anti-Jo1 (n = 4) and anti-PL12 (n = 3) were the most frequent autoantibodies. At myocarditis diagnosis, most patients (11/14, 79%) had active myositis, defined as elevated creatine kinase and/or muscle weakness; required hospitalization (13/14, 93%); and had reduced left ventricular ejection fraction (LVEF < 50%; 10/14, 71%). Despite intensification of immunosuppression, the 5-year overall survival rate from IIM diagnosis was 84%, and the 5-year overall survival rate from myocarditis diagnosis was 53%. Systolic dysfunction (LVEF < 40%) at final evaluation was observed in all expired patients (n = 6).

Conclusion

Clinical presentations of myocarditis in this select cohort of patients with IIM were severe and heterogeneous with poor outcomes despite intensification of immunosuppression, potentially reflecting late detection of myocarditis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MyocarditisMyositisHumansMaleFemaleRetrospective StudiesStroke VolumeVentricular Function, LeftAutoantibodies

Stichwörter der Autor:innen

antisynthetase syndromecardiacdermatomyositismyocarditismyositispolymyositis

Substanzen

Autoantibodies

Autor:innen und Institutionen

  • M.P. Chung, MD, MS, W. Kelly, BS, C.A. Mecoli, MD, MHS, J. Albayda, MD, L. Christopher-Stine, MD, MPH, J.J. Paik, MD, MHS, Division of Rheumatology, Johns Hopkins University School of Medicine; mchung25@jh.edu.
  • J. Lovell, MD, N.A. Gilotra, MD, Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • M.P. Chung, MD, MS, W. Kelly, BS, C.A. Mecoli, MD, MHS, J. Albayda, MD, L. Christopher-Stine, MD, MPH, J.J. Paik, MD, MHS, Division of Rheumatology, Johns Hopkins University School of Medicine.

ORCID-Profile: Melody P Chung, Christopher A Mecoli, Jemima Albayda, Lisa Christopher-Stine, Nisha A Gilotra, Julie J Paik

Förderung

  • NIAMS NIH HHS
  • NHLBI NIH HHS

Zitieren

APA

Chung, M. P., Lovell, J., Kelly, W., Mecoli, C. A., Albayda, J., Christopher-Stine, L., Gilotra, N. A., & Paik, J. J. (2023). Myocarditis in Patients With Idiopathic Inflammatory Myopathies: Clinical Presentation and Outcomes. The Journal of Rheumatology, 50(8), 1039-1046. https://doi.org/10.3899/jrheum.220989

Vancouver

Chung MP, Lovell J, Kelly W, Mecoli CA, Albayda J, Christopher-Stine L, et al. Myocarditis in Patients With Idiopathic Inflammatory Myopathies: Clinical Presentation and Outcomes. The Journal of Rheumatology. 2023;50(8):1039-1046. doi:10.3899/jrheum.220989

BibTeX
@article{Chung2023,
  author = {Chung, Melody P and Lovell, Jana and Kelly, William and Mecoli, Christopher A and Albayda, Jemima and Christopher-Stine, Lisa and Gilotra, Nisha A and Paik, Julie J},
  title = {Myocarditis in Patients With Idiopathic Inflammatory Myopathies: Clinical Presentation and Outcomes},
  journal = {The Journal of Rheumatology},
  year = {2023},
  volume = {50},
  number = {8},
  pages = {1039--1046},
  doi = {10.3899/jrheum.220989}
}
Kostenlos starten →